Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
批准号:
10579963
负责人:
Niroshana Anandasabapathy
金额:
$73.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2027-01-31
关键词:
2019-nCoVATAC-seqAdoptive Cell TransfersAntigen PresentationAntigensApoptoticAutoantigensAutoimmunityBasic ScienceBehaviorBiologyBloodBone MarrowCISH geneCandidaCell MaturationCellsCellular biologyChromatinClinicalCuesDataDendritic CellsDevelopmentDiseaseEnvironmentEquilibriumFaceGenesGoalsHealthHomeostasisHumanIFNG geneImmuneImmune ToleranceImmune systemImmunityIndividualInfectionInflammationInflammatoryInfluenzaInterferon Type IIInterventionKnowledgeLicensingLoxP-flanked alleleLungMapsMeasuresModelingMolecularMolecular TargetMusMyelogenousNF-kappa BOrganismPathogen detectionPathogenesisPathogenicityPathway interactionsPatternPeptide/MHC ComplexPeripheralPopulationPositioning AttributeProteinsPsoriasisPublic HealthPublishingReporterSelf ToleranceSignal TransductionSimplexvirusSiteSkinStimulusSurveysSystems BiologyT-LymphocyteTestingTimeTissue DifferentiationTissuesTranscriptTumor ImmunityVaccinationVaccinesViralVirusVitiligoWorkautoinflammationcancer cellcell motilitycell typeclinically relevantcombatconditioningdrug developmentimmunogenicimprovedin vivoinsightlymphoid organmelanomamodifiable behaviorneuroinflammationpathogenpharmacologicpreservationpreventprogenitorprogramsresponsesource localizationtissue repairtranscription factortranscriptometumorvaccination strategyviral DNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary:
The immune system faces the external world and encounters pathogens, including viruses in barrier tissues (e.g.
skin, lung, and gut). There the immune system must detect and respond to pathogens, while simultaneously
preventing autoimmunity and promoting tissue repair. Dendritic cells (DC) in tissue are the key cells which
balance self-tolerance (preventing destruction of our bodies tissues) with pathogen surveillance.
The goal of this application is to understand how DCs develop uniquely and are adapted in the tissue to perform
and balance these functions. We have recently identified an important new mechanism, and a new molecular
target that dictates how DC in tissues differentiate in ways that impact their function. The goal of this proposal is
to gain a deeper understanding of DC biology along this regulatory axis, as a critical first step to intervene upon
tissue DC to restore health, when dysregulated. This would advance better immunization strategies as tissue
DCs are necessary for vaccine, viral, and cancer immunity. This application enables us to now test, for the first
time, how our myeloid compartment is architected to balance immune tolerance and pathogen surveillance in
barrier tissue sites.
Upon completion of this project we will understand how DCs in tissue are locally conditioned to behave in a site-
specific manner. We will gain an appreciation of how shared environmental sensing patterns are balanced
against individual cell identities, and tailored to specific pathogenic contexts. We will understand how local cues
modify the behavior of DCs, positioning us to test this in disease states. We will also identify DC behaviors that
are modifiable by local cues, enabling improved intervention on DC during disease pathogenesis and a better
model for successful DC development to improve adoptive cell therapy. The insights here are foundational, fill a
critical knowledge gap, and represent basic science advances needed to advance human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High-parametric flow cytometry cell sorter for human immunology studies.
-
批准号:10632888
-
项目类别:
-
资助金额:$81.69万
-
财政年份:2023
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
-
批准号:10378337
-
项目类别:
-
资助金额:$74.12万
-
财政年份:2022
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:9684364
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2018
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:9768889
-
项目类别:
-
资助金额:$46.05万
-
财政年份:2018
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:10004498
-
项目类别:
-
资助金额:$45.57万
-
财政年份:2018
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:9397655
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2016
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:9258870
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2016
-
负责人:Niroshana Anandasabapathy
-
依托单位:
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
-
批准号:9353720
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2016
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:8609183
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:9096028
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:8494576
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:8384269
-
项目类别:
-
资助金额:$5.59万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:8882264
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells
-
批准号:8706042
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2012
-
负责人:Niroshana Anandasabapathy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: